1. Home
  2. TMDX vs AVNT Comparison

TMDX vs AVNT Comparison

Compare TMDX & AVNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • AVNT
  • Stock Information
  • Founded
  • TMDX 1998
  • AVNT 1927
  • Country
  • TMDX United States
  • AVNT United States
  • Employees
  • TMDX N/A
  • AVNT N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • AVNT Major Chemicals
  • Sector
  • TMDX Health Care
  • AVNT Industrials
  • Exchange
  • TMDX Nasdaq
  • AVNT Nasdaq
  • Market Cap
  • TMDX 4.7B
  • AVNT 4.4B
  • IPO Year
  • TMDX 2019
  • AVNT 1993
  • Fundamental
  • Price
  • TMDX $86.26
  • AVNT $51.33
  • Analyst Decision
  • TMDX Buy
  • AVNT Strong Buy
  • Analyst Count
  • TMDX 10
  • AVNT 5
  • Target Price
  • TMDX $138.20
  • AVNT $54.50
  • AVG Volume (30 Days)
  • TMDX 2.2M
  • AVNT 523.4K
  • Earning Date
  • TMDX 10-28-2024
  • AVNT 10-31-2024
  • Dividend Yield
  • TMDX N/A
  • AVNT 2.11%
  • EPS Growth
  • TMDX N/A
  • AVNT N/A
  • EPS
  • TMDX 0.94
  • AVNT 1.64
  • Revenue
  • TMDX $401,090,000.00
  • AVNT $3,212,900,000.00
  • Revenue This Year
  • TMDX $83.25
  • AVNT $5.38
  • Revenue Next Year
  • TMDX $26.27
  • AVNT $4.41
  • P/E Ratio
  • TMDX $94.29
  • AVNT $31.21
  • Revenue Growth
  • TMDX 109.09
  • AVNT N/A
  • 52 Week Low
  • TMDX $63.86
  • AVNT $33.64
  • 52 Week High
  • TMDX $177.37
  • AVNT $54.68
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 31.88
  • AVNT 59.19
  • Support Level
  • TMDX $82.70
  • AVNT $50.52
  • Resistance Level
  • TMDX $98.88
  • AVNT $52.27
  • Average True Range (ATR)
  • TMDX 5.52
  • AVNT 1.64
  • MACD
  • TMDX 1.30
  • AVNT 0.27
  • Stochastic Oscillator
  • TMDX 15.58
  • AVNT 63.61

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About AVNT Avient Corporation

Avient Corp manufactures and sells a variety of chemical and plastic-based products to designers and processors of plastics. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

Share on Social Networks: